SHH and liver cancer: In combination with the suppressed stem cell properties of CD90+ liver cancer cells transfected with Gli siRNAs (Figure 4), these results persuasively demonstrated that the stem cell properties of CD90+ liver cancer cells were mediated by activation of SHH/Gli‐related signalling pathways during liver cancer progression.